Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Background Malignant pleural effusion (MPE) is a common problem for people with cancer
as a result of malignant infiltration of the pleura. It is usually associated with considerable …

Background: Recommendations regarding key aspects related to the diagnosis and
pharmacological treatment of lymphangioleiomyomatosis (LAM) were recently published …

Malignant pleural effusions (MPEs) are an important complication for patients with
intrathoracic and extrathoracic malignancies. Median survival after diagnosis of an MPE is 4 …

Goals/objectives To review the scientific evidence on symptoms and specific complications
that are associated with lung cancer, and the methods available to palliate those symptoms …

Background Malignant pleural effusion (MPE) is a common problem for people with cancer
and usually associated with considerable breathlessness. A number of treatment options are …

Background Talc pleurodesis has been widely used to control malignant pleural effusion;
however, it is still not clear whether talc pleurodesis is more effective than other local …

Squalene is a natural dehydrotriterpenic hydrocarbon (C30H50) with six double bonds, an
intermediate for the biosynthesis of phytosterol/cholesterol in plants/animals and humans …

Malignant pleural effusions (MPEs) complicate the clinical course of patients with a broad
array of malignancies, which are most often due to lymphomas or carcinomas of the breast …

The approach to management of malignant pleural effusions (MPE) has changed over the
past few decades. The key goals of MPE management are to relieve patient symptoms using …